Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

被引:264
作者
Petrovics, G
Liu, AJ
Shaheduzzaman, S
Furasato, B
Sun, C
Chen, YM
Nau, M
Ravindranath, L
Chen, YD
Dobi, A
Srikantan, V
Sesterhenn, IA
McLeod, DG
Vahey, M
Moul, JW
Srivastava, S [1 ]
机构
[1] Ctr Prostate Dis Res, Dept Surg, Rockville, MD 20852 USA
[2] Uniformed Serv Univ Hlth Sci, US Mil Canc Inst, Rockville, MD 20852 USA
[3] Armed Forces Inst Pathol, Dept Genitourinary Pathol, Washington, DC 20306 USA
[4] Walter Reed Army Inst Res, Lab Funct Genom, Rockville, MD 20850 USA
[5] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA
[6] Walter Reed Army Med Ctr, Urol Serv, Washington, DC 20307 USA
关键词
ERG1; ETS transcription factor family; prostate cancer; proto-oncogene; overexpression;
D O I
10.1038/sj.onc.1208518
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcription factors encoded by the ETS family of genes are central in integrating signals that regulate cell growth and differentiation, stress responses, and tumorigenesis. This study, analysing laser microdissected paired benign and malignant prostate epithelial cells from prostate cancer (CaP) patients ( n = 114; 228 specimen) by GeneChip and quantitative real-time RT-PCR, identifies ETS-related gene ( ERG), a member of the ETS transcription factor family, as the most frequently overexpressed proto-oncogene in the transcriptome of malignant prostate epithelial cells. Combined quantitative expression analysis of ERG with two other genes commonly overexpressed in CaP, AMACR and DD3, revealed overexpression of at least one of these three genes in virtually all CaP specimen ( 54 of 55). Comprehensive evaluation of quantitative ERG1 expression with clinicopathological features also suggested that ERG1 expression level in prostate tumor cells relative to benign epithelial cells is indicator of disease-free survival after radical prostatectomy.
引用
收藏
页码:3847 / 3852
页数:6
相关论文
共 19 条
[1]   Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21:: Amplification discloses overexpression of APP, ETS2, and ERG genes [J].
Baldus, CD ;
Liyanarachchi, S ;
Mrózek, K ;
Auer, H ;
Tanner, SM ;
Guimond, M ;
Ruppert, AS ;
Mohamed, N ;
Davuluri, RV ;
Caligiuri, MA ;
Bloomfield, CD ;
de la Chapelle, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) :3915-3920
[2]  
Bussemakers MJG, 1999, CANCER RES, V59, P5975
[3]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826
[4]   Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers [J].
Gavrilov, D ;
Kenzior, O ;
Evans, M ;
Calaluce, R ;
Folk, WR .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (08) :1033-1040
[5]  
Gelmann EP, 2003, CRIT REV ONCOL HEMAT, V46, pS11
[6]  
HART AH, 1995, ONCOGENE, V10, P1423
[7]   Ets proteins in biological control and cancer [J].
Hsu, T ;
Trojanowska, M ;
Watson, DK .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (05) :896-903
[8]   Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma [J].
Hurt, EM ;
Wiestner, A ;
Rosenwald, A ;
Shaffer, AL ;
Campo, E ;
Grogan, T ;
Bergsagel, PL ;
Kuehl, WM ;
Staudt, LM .
CANCER CELL, 2004, 5 (02) :191-199
[9]   Oncogenes and tumor suppressor genes in prostate cancer [J].
Isaacs, W ;
Kainu, T .
EPIDEMIOLOGIC REVIEWS, 2001, 23 (01) :36-41
[10]  
Liu AY, 1997, PROSTATE, V30, P145, DOI 10.1002/(SICI)1097-0045(19970215)30:3<145::AID-PROS1>3.0.CO